Rheumatoid Arthritis: A Brief Overview of the Treatment.

Article Details

Citation

Copy to clipboard

Bullock J, Rizvi SAA, Saleh AM, Ahmed SS, Do DP, Ansari RA, Ahmed J

Rheumatoid Arthritis: A Brief Overview of the Treatment.

Med Princ Pract. 2018;27(6):501-507. doi: 10.1159/000493390. Epub 2018 Sep 2.

PubMed ID

30173215 [ View in PubMed

]

Abstract

Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic autoimmune disease, affecting the joints with varying severity among patients. The risk factors include age, gender, genetics, and environmental exposure (cigarette smoking, air pollutants, and occupational). Many complications can follow, such as permanent joint damage requiring arthroplasty, rheumatoid vasculitis, and Felty syndrome requiring splenectomy if it remains unaddressed. As there is no cure for RA, the treatment goals are to reduce the pain and stop/slow further damage. Here, we present a brief summary of various past and present treatment modalities to address the complications associated with RA.

DrugBank Data that Cites this Article

Drugs

Adalimumab

Drug Interactions

• Approved
• Vet approved
• Nutraceutical
• Illicit
• Withdrawn
• Investigational
• Experimental
• All Drugs

Drugs	Interaction
Integrate drug-drug interactions in your software
Etanercept Adalimumab	The risk or severity of infection can be increased when Adalimumab is combined with Etanercept.
Golimumab Adalimumab	The risk or severity of infection can be increased when Adalimumab is combined with Golimumab.
Rituximab Adalimumab	The risk or severity of infection can be increased when Adalimumab is combined with Rituximab.
Sarilumab Adalimumab	The risk or severity of infection can be increased when Adalimumab is combined with Sarilumab.